ZBD-0276

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZBD-0276
Drug Alias NameZBD-0276
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTh1 cells inhibitorsTh2 cells inhibitorsTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHeilongjiang Zbd Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHeilongjiang Zbd Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A